In line with the study, the research team discovered that the cholesterol byproduct called 27-hydroxycholesterol or 27HC plays a central role in facilitating metastasis in animal models of breast cancer. The scientists used mice models fed with a high cholesterol diet as part of the study, noting that animal models fed with a high cholesterol diet have shown a significant increase in tumor growth and metastasis.
However, the scientists have found that breast cancer cells did not appear to metastasize when they manually inhibited the breast cancer cell enzymes associated with 27HC.
Cholesterol byproduct spurs metastasis by manipulating immune cells
The scientists observed that 27HC accelerates breast cancer metastasis by negatively influencing certain immune cells. The experts have noted that the cholesterol byproduct appears to change the function of immune cells at metastatic sites. This means that 27HC coaxes both the T-cells and neutrophils into thinking that the cancer cells are harmless. Thus, the process tricks the immune cells to allow the cancer to spread instead of fending off tumor growth.
“We found that 27HC is not working on the cancer cells themselves, but it’s actually working on the immune cells, or white blood cells. And what it does is it hijacks those cells and redirects them from fighting cancer to promoting cancer. So this allows the cancer to spread unchecked," lead study author Erik R. Nelson has stated in a Cardiovascular Business article.
Upon further research, the scientists discovered that 27HC prompts a similar effect on other solid tumor sites such as those observed in colon cancer, lung cancer, melanoma, and pancreatic cancer. The research team suggests that inhibiting the cholesterol byproduct's action may bolster treatment.
"We’re currently working with our clinical partners to determine whether the effects we see in mice also hold true in human tissue. The other thing that we’re currently working on is to develop better inhibitors of 27HC. We’re hopeful that our studies will lead to new therapeutic options for the treatment of patients with metastatic disease of breast cancer but also of other solid tumors,” according to Nelson.
The research team is set to work with health experts at the Carle Foundation Hospital in Urbana, Illinois to examine whether the cholesterol byproduct may have a similar effect on humans. (Related: Decrease your risk of breast cancer by avoiding these foods.)
Sources include:
Please contact us for more information.
